Chemo Gets the Job Done Alone

A long-term risk analysis of Hodgkin lymphoma patients shows that the traditional practice of using radiation together with chemotherapy may be too much, causing more problems without extending life expectancy.

Protecting Boys From Prostate Cancer

Circumcising male babies has been done for religious reasons for centuries. The practice has been consistent in the United States with the exception of a downturn in the 1970s.

Cancer Therapy May Backfire

Tumors grow and spread in one of two ways - by invading nearby resources, or by sending little pieces into the bloodstream to colonize new areas.

Weightlifting First Controls Diabetes

Unlike type 2 diabetes patients, people with type 1 diabetes have to be careful when they exercise. Physical activity can knock their blood sugar levels out of control.

Safer Treatment for Skin Lymphoma

Part of the process of developing and testing drugs involves seeing if treatments work in similar conditions, and science is full of surprises.

Switch Red Meat for the Other Meats

Digging into that steak may leave you with more than a full tummy - red meat also appears to be associated with a higher risk of dying, from cancer, heart attack, stroke or in general.

Which Weight-Loss Surgery for Diabetes?

For some people, losing weight is not as easy as dieting and exercising. Sometimes, extremely overweight people need surgery to protect them from the dangers of obesity, such as diabetes. But which surgery is best?

New "Theranostic" Drugs Diagnose and Treat

Acute lymphoblastic leukemia (ALL) is the most common type of childhood cancer, diagnosed in some 5,000 children every year in the United States.

Genetic Analysis Finds New Leukemia Therapy

The computational power available to researchers has grown exponentially over the years, allowing broad analysis of genetics involved in cancer to get new ideas for exploring new methods of therapy.

Prevnar 13 Shown to be Immunogenic in Adolescents

Pfizer Inc. announced Prevnar 13 (Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein]) met all study endpoints, showing immunogenicity and establishing a safety profile in children and adolescents aged 5 through 17 years.

Pages

Subscribe to rxwiki.com RSS